Risks associated with the use of intravenous immunoglobulin
- 31 October 2003
- journal article
- review article
- Published by Elsevier BV in Transfusion Medicine Reviews
- Vol. 17 (4), 241-251
- https://doi.org/10.1016/s0887-7963(03)00038-5
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Multiple complications of IVIG therapy in a patient with Guillain-Barré syndromeAmerican Journal of Hematology, 2001
- In vivoAdministration of Intravenous Immunoglobulin (IVIg) can Lead to Enhanced Erythrocyte SequestrationJournal of Autoimmunity, 1999
- Safety of intravenous immunoglobulin with regard to hepatitis c virusClinical Therapeutics, 1996
- Randomized trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma: Chapel HM, Lee M, Hargreaves R, et al. Lancet 343:1059–1063, 1994Transfusion Medicine Reviews, 1995
- From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994JAMA, 1994
- Detection and characterization of hepatitis C virus RNA in immune globulinsTransfusion, 1994
- Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myelomaThe Lancet, 1994
- Aseptic Meningitis Following Administration of Intravenous Immune GlobulinClinical Infectious Diseases, 1992
- Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapyThe Lancet, 1992
- Transient Neutropenia Induced by Intravenous Immune GlobulinThe New England Journal of Medicine, 1992